What Is HPLC?

HPLC stands for High-Performance Liquid Chromatography. It's the gold standard analytical technique for measuring peptide purity. If you've ever seen "≥99% HPLC verified" on a product description, this is the test they're referring to.

In simple terms: HPLC separates a peptide sample into all of its individual components and measures how much of each is present. It's like running a mixture through a very sophisticated filter that tells you exactly what percentage is your target peptide vs. impurities [1].

How HPLC Works (Simplified)

  1. Dissolve the sample — the peptide is dissolved in a compatible solvent
  2. Inject into a column — the solution is pushed through a packed column at high pressure
  3. Separation occurs — different molecules travel through the column at different speeds based on their chemical properties
  4. Detection — a UV detector measures each component as it exits the column
  5. Chromatogram — the output is a graph showing peaks; each peak represents a different component

The main peak's area, divided by total peak area, gives you the purity percentage. A result of "≥99.1% purity" means that 99.1% of the sample's signal comes from the intended peptide.

What's a Certificate of Analysis (COA)?

A COA is a document from an analytical testing laboratory that reports the results of quality testing on a specific batch of a compound. For peptides, a proper COA typically includes:

Red Flags on a COA

When evaluating a COA, watch for these warning signs:

"Third-party tested" means the testing was done by a lab independent of the manufacturer. This matters because it eliminates conflicts of interest in reporting results.

Why Purity Matters in Research

For any in-vitro experiment, impurities can confound results. If a researcher is studying BPC-157's effect on cell proliferation but the sample contains 5% unidentified impurities, you can't be certain whether observed effects come from BPC-157 or the contaminants [2].

This is why pharmaceutical-grade research requires ≥95% purity minimum, with most serious research using ≥98% or ≥99% purity grade peptides [3].

Sources

  1. Snyder, L.R. et al. (2010). Introduction to Modern Liquid Chromatography, 3rd Edition. Wiley. Chapter 1: HPLC Fundamentals.
  2. Fosgerau, K. & Hoffmann, T. (2015). "Peptide therapeutics: current status and future directions." Drug Discovery Today, 20(1), 122-128. PubMed: 25450771
  3. U.S. Pharmacopeia (2023). USP General Chapter ⟨621⟩ "Chromatography." usp.org
← Back to BlogNext: Future of Peptide Therapeutics →